Facebook Twitter RSS Feed
 - child

Fifteen of the 25 high-risk devices approved by the FDA between 2007 and 2011 for use in children were cardiovascular therapeutics, with approval for 22 of the 25 devices based on studies that enrolled patients 18 years and older, according to a study published online April 14 in Pediatrics.

 - Gavel and stethoscope

Medical malpractice claims and costs are likely to rise as changes from the Patient Protection and Affordable Care Act take effect, an analysis by RAND Corp. predicted.

 - sad

Some patients hospitalized for various cardiac illnesses who had or developed mental health conditions fared better under a low-intensity care program in a clinical trial. The results were published online April 14 in JAMA Internal Medicine.

 - Gavel

A federal court called for a preliminary injunction limiting the sale of the CoreValve device in the U.S. but granted a reprieve before the injunction is scheduled to go into effect.

 - telemonitor

Providers who integrate remote care management (RCM) strategies into their post-discharge protocols will be well positioned as reimbursement transitions from fee for service to value based, an executive wrote April 4 in the Health Affairs blog. His hospital reduced congestive heart failure 30-day readmissions by 4 percent using RCM technology.